Member Benefits by Sector: Startups
BIO recognizes the unique needs of emerging companies and helps you achieve your goals. From advocating for pro-innovation tax policies to encouraging an economic and policy environment to foster investment, we focus on critical issues affecting smaller companies and build programs to enhance your development.
BIO advocates on behalf of our members on issues related to taxes, financial services, securities, and accounting policies that impact companies and biotech capital formation. Areas of interest include the JOBS Act, Sarbanes-Oxley (SOX) Section 404(b), proxy advisory firms, short selling transparency, market structure reform, tick size, accounting and auditing standards, and SEC life science reporting topics.
BIO works to engage the Committee on Foreign Investment in the U.S. (CFIUS) in it's rulemaking process to avoid an undue impact on the biotechnology sector's ability to enter into global research partnerships and attract foreign investments.
BIO recognizes the need for capital and collaboration faced by startups. Therefore we host more than a dozen events throughout the year to help small biotechs connect with potential investors, licensors, and partners. BIO members receive discounts on registration, presentation, and exhibition fees at BIO events.
Explore webinars, BIO panels, comments, and more on this members only site.
Meet key partners to grow your business at our events around the world.
Join fellow BIO members on Capitol Hill and talk with Members of Congress.
“Our ability to affect change through our involvement on the Finance and Tax Committee at BIO has been extremely beneficial to us as a small cap public biotech company. In particular, BIO was able to add a revenue requirement for SOX 404(b) qualification. Accordingly, along with our other small cap biotech peers, we will be able to further delay implementing this costly and burdensome regulation."
Marc Belsky
Chief Financial Officer
Kezar Life Sciences
